123 related articles for article (PubMed ID: 228835)
21. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
Han T; Takita H
Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
[No Abstract] [Full Text] [Related]
22. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
[No Abstract] [Full Text] [Related]
23. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
24. Thymus derived rosette forming cell counts and lymphocyte response to phytohaemagglutinin in animals affected with squamous cell carcinoma of horn.
Kuchroo V; Gupta RK; Kalra DS
Res Vet Sci; 1981 Sep; 31(2):144-6. PubMed ID: 6976603
[TBL] [Abstract][Full Text] [Related]
25. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.
Vánky F; Péterffy A; Böök K; Willems J; Klein E; Klein G
Cancer Immunol Immunother; 1983; 16(1):17-22. PubMed ID: 6605800
[TBL] [Abstract][Full Text] [Related]
26. Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer.
Masuno T; Ikeda T; Yokota S; Komuta K; Ogura T; Kishimoto S
Cancer Res; 1986 Aug; 46(8):4195-9. PubMed ID: 3015385
[TBL] [Abstract][Full Text] [Related]
27. In vitro lymphocyte blastogenesis: a prognostic test in patients with neoplastic disease.
Han T
J Surg Oncol; 1973 Jun; 5(6):567-74. PubMed ID: 4129688
[No Abstract] [Full Text] [Related]
28. [Evaluation of the immunologic system in patients with small cell and squamous cell lung cancer during the early stage of treatment].
Janicka G; Chyczewska E; Przylipiak M; Kowal E
Pol Tyg Lek; 1985 Aug; 40(34):963-6. PubMed ID: 2999734
[No Abstract] [Full Text] [Related]
29. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
30. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
31. [A study about the ability of interleukin-2 production, interleukin-2 receptor expression by lymphocytes from patients with lung cancer].
Liu SB
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Dec; 15(6):349-51, 380. PubMed ID: 1339618
[TBL] [Abstract][Full Text] [Related]
32. Non-specific immunostimulation in bronchogenic cancer.
Israel L
Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
[No Abstract] [Full Text] [Related]
33. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer].
Kozielski J; Seweryn J
Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292
[No Abstract] [Full Text] [Related]
34. Lymphocyte subsets in lung cancer.
Wesselius LJ; Wheaton DL; Manahan-Wahl LJ; Sherard SL; Taylor SA; Abdou NA
Chest; 1987 May; 91(5):725-9. PubMed ID: 3032522
[TBL] [Abstract][Full Text] [Related]
35. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
Nishikawa H; Yasaki S; Yoshimoto T; Sakatani M; Itoh M; Masuno T; Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
[TBL] [Abstract][Full Text] [Related]
36. Colony formation by subpopulations of human T lymphocytes. II. Characteristics of colony cells and colony suppressor cells.
Claësson MH; Søonderstrup-Hansen G; Poulsen PB
Scand J Immunol; 1981; 13(4):395-400. PubMed ID: 6458086
[TBL] [Abstract][Full Text] [Related]
37. Immune status in lung cancer: effects of BCG immunotherapy.
Gross NJ; Eddie-Quartey AC
Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
[TBL] [Abstract][Full Text] [Related]
38. Tumor histology and the immunoregulatory T lymphocyte subsets in lung cancer patients.
Kumano N; Koinumaru S; Suzuki S; Ishikawa T; Oizumi K; Konno K
Tohoku J Exp Med; 1986 Dec; 150(4):483-4. PubMed ID: 3031845
[TBL] [Abstract][Full Text] [Related]
39. Immunocompetence in lung cancer. Relationship to extent of tumor burden and histologic type.
Pillai MR; Balaram P; Padmanabhan TK; Abraham T; Hareendran NK; Nair MK
Cancer; 1989 Nov; 64(9):1853-8. PubMed ID: 2551475
[TBL] [Abstract][Full Text] [Related]
40. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research].
Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C
Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
